Elias Aboujaoude, MD, MA

Publication Details

• Double-blind treatment with oral morphine in treatment-resistant obsessive-compulsive disorder.

  Koran LM, Aboujaoude E, Bullock KD, Franz B, Gamel N, Elliott M. J Clin Psychiatry. 2005; 66 (3): 353-9

  Obsessive-compulsive disorder (OCD) often responds inadequately to serotonin reuptake inhibitors (SRIs). A case series reported substantial response to once-weekly oral morphine. We conducted a placebo-controlled, double-blind trial to investigate whether once-weekly oral morphine is effective in SRI-resistant OCD.

  PubMedID: 15766302